Lynkuet 60 mg, Weichkapseln

7680699170029 CH-69917 Weichkapseln
Lynkuet 60 mg, Weichkapseln
Lynkuet 60 mg, Weichkapseln
Lynkuet 60 mg, Weichkapseln
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Kapsel(n)
Galenic form
Weichkapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/08/2026
Patient information leaflet
Français
04/08/2026
Patient information leaflet
Italien
04/08/2026
Summary of Product Characteristics
Allemand
04/08/2026
Summary of Product Characteristics
Français
04/08/2026
Summary of Product Characteristics
Italien
04/08/2026

Detailed composition

Substance Quantity Type Category
elinzanetantum
60.0 MG Substance Wirkstoff (Principe actif)
int-rac-alpha-tocopherolum
- Substance HNIDK
macrogolglyceridorum caprylocaprates
- Substance HNIDK
glyceroli monocaprylocapras
- Substance HNIDK
glyceroli mono-oleas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
gelatina
- Substance HNIDK
sorbitolum liquidum partim deshydricum
- Substance HNIDK
sorbitolum
75.0 MG Substance HBESI
glycerolum
- Substance HNIDK
E 171
- Substance FNIDK
ammoniae solutio concentrata
- Substance HNIDK
alcohol isopropylicus
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
polyvinylis acetas phtalas
- Substance HNIDK
aqua purificata
- Substance HNIDK
ethanolum
- Substance HNIDK
ethylis acetas
- Substance HNIDK
E 171
- Substance FNIDK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
69917
Drug name
Lynkuet, Weichkapseln
Galenic form
KAPWE
ATC Code
G02CX07
Authorization status
Z
Dispensing category
B
First authorization
05/08/2025
Authorization expiration date
04/08/2030
IT Number
09.98.0.
Domain
Human medicine
Field of application
Behandlung moderater bis schwerer vasomotorischer Symptome (VMS) -bei postmenopausalen Patientinnen -die durch adjuvante endokrine Therapie im Zusammenhang mit Brustkrebs bei erwachsenen Patientinnen verursacht werden

Package details

Description (FR)
LYNKUET caps moll 60 mg 60 pce
Description (DE)
LYNKUET Weichkaps 60 mg 60 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Other package sizes (2)

LYNKUET caps moll 60 mg 24 pce
24 KAP
GTIN: 7680699170012
View
None
3 x 60 KAP
GTIN: None
Not in V1
Buy us a coffee Explore the data